Develops novel radiotherapeutics to treat various cancers, advancing targeted therapies in the field of oncology.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Radionetics Oncology is a clinical stage radiopharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications and is poised to capitalize on the increasing demand for novel radiotherapeutics.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Radionetics Oncology Management Team
Investors
5AM Ventures
Crinetics Pharmaceuticals
DCVC Bio
Frazier Life Sciences Management, L.P.
GordonMD Global Investments
Radionetics Oncology Valuations & Financials
View real-time NPM data on Radionetics Oncology stock including daily Radionetics Oncology stock price estimates, valuation history, and historical share price information. Access Radionetics Oncology financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Radionetics Oncology pricing across six independent market signals. Looking for private company due diligence data sources on Radionetics Oncology? Get in touch to learn more.
Similar Companies
like Radionetics Oncology
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Tandem PV
Climate & Sustainability
Enables cleaner solar generation by layering perovskite atop silicon to boost panel efficiency and endurance with low-energy manufacturing.
CrowdSmart
AI & Machine Learning
A cloud-based platform that blends human input and AI to help organizations clarify problems, generate ideas, and predict which solutions will succeed.
Sonara
Healthcare & Life Sciences
Enables remote medication monitoring and hybrid care for patients undergoing addiction treatment.
Magnetic Insight
Healthcare & Life Sciences
Enables high-contrast diagnostics using magnetic particles instead of radiation for safer, more precise imaging.
FAQ
We have answers
Radionetics Oncology stock does not trade on public stock exchanges. Radionetics Oncology stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Radionetics Oncology stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Radionetics Oncology Stock does not trade on public stock exchanges. In order to sell Radionetics Oncology shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Radionetics Oncology does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Radionetics Oncology share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Radionetics Oncology stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Radionetics Oncology stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Radionetics Oncology stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Radionetics Oncology is a private company and has not had an IPO. There is currently no Radionetics Oncology IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Radionetics Oncology IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
